Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal
- 1 August 2015
- journal article
- research article
- Published by Elsevier BV in The Breast
- Vol. 24 (4), 513-523
- https://doi.org/10.1016/j.breast.2015.02.031
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)The Breast, 2014
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- BRCA in breast cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2011
- Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2010
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Sicily statement on evidence-based practiceBMC Medical Education, 2005
- Evidence-Based MedicineJAMA, 1992